Perceptive Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.5M | Sell |
|
|||||
|
2025
Q1 | $175M | Sell |
|
|||||
|
2024
Q4 | $228M | Sell |
|
|||||
|
2024
Q3 | $300M | Hold |
|
|||||
|
2024
Q2 | $278M | Hold |
|
|||||
|
2024
Q1 | $331M | Hold |
|
|||||
|
2023
Q4 | $398M | Buy |
|
|||||
|
2023
Q3 | $337M | Buy |
|
|||||
|
2023
Q2 | $347M | Hold |
|
|||||
|
2023
Q1 | $307M | Buy |
|
|||||
|
2022
Q4 | $338M | Buy |
|
|||||
|
2022
Q3 | $286M | Buy |
|
|||||
|
2022
Q2 | $289M | Sell |
|
|||||
|
2022
Q1 | $261M | Buy |
|
|||||
|
2021
Q4 | $307M | Hold |
|
|||||
|
2021
Q3 | $254M | Buy |
|
|||||
|
2021
Q2 | $223M | Buy |
|
|||||
|
2021
Q1 | $226M | Sell |
|
|||||
|
2020
Q4 | $580M | Sell |
|
|||||
|
2020
Q3 | $355M | Sell |
|
|||||
|
2020
Q2 | $380M | Hold |
|
|||||
|
2020
Q1 | $233M | Buy |
|
|||||
|
2019
Q4 | $245M | Buy |
|
|||||
|
2019
Q3 | $197M | Buy |
|
|||||
|
2019
Q2 | $268M | Sell |
|
|||||
|
2019
Q1 | $294M | Buy |
|
|||||
|
2018
Q4 | $192M | Buy |
|
|||||
|
2018
Q3 | $250M | Buy |
|
|||||
|
2018
Q2 | $313M | Hold |
|
|||||
|
2018
Q1 | $301M | Buy |
|
|||||
|
2017
Q4 | $257M | Hold |
|
|||||
|
2017
Q3 | $270M | Buy |
|
|||||
|
2017
Q2 | $174M | Hold |
|
|||||
|
2017
Q1 | $123M | Hold |
|
|||||
|
2016
Q4 | $86M | Buy |
|
|||||
|
2016
Q3 | $104M | Sell |
|
|||||
|
2016
Q2 | $83.2M | Hold |
|
|||||
|
2016
Q1 | $129M | Hold |
|
|||||
|
2015
Q4 | $148M | Buy |
|
|||||
|
2015
Q3 | $176M | Hold |
|
|||||
|
2015
Q2 | $204M | Hold |
|
|||||
|
2015
Q1 | $157M | Hold |
|
|||||
|
2014
Q4 | $120M | Buy |
|
|||||
|
2014
Q3 | $73.4M | Hold |
|
|||||
|
2014
Q2 | $41.2M | Buy |
|
|||||
|
2014
Q1 | $2M | Buy |
|